Abel Peter

Dr. Abel Peter is a Research Fellow at the University of Central Lancashire, specializing in oncology and immunotherapy. He holds a PhD from the University of Central Lancashire (2017) and has contributed to groundbreaking research on gliomas, CAR T cell therapy, and biomarker discovery. His work combines molecular biology, neuro-oncology, and translational medicine, with a focus on developing novel therapeutic strategies for brain tumors. Key contributions include studies on cytokine secretion in malignant gliomas and the use of Drosophila models to understand disease evolution.

His research has been published in high-impact journals such as Neuro-Oncology and Neuroscience and Medicine, and he collaborates with interdisciplinary teams across the University’s research centers. While no specific awards or student advisees are listed, his work demonstrates a strong commitment to advancing cancer research through innovative methodologies.